Does PONATINIB Cause Leukaemia recurrent? 66 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Leukaemia recurrent have been filed in association with PONATINIB (Iclusig). This represents 0.7% of all adverse event reports for PONATINIB.
66
Reports of Leukaemia recurrent with PONATINIB
0.7%
of all PONATINIB reports
24
Deaths
31
Hospitalizations
How Dangerous Is Leukaemia recurrent From PONATINIB?
Of the 66 reports, 24 (36.4%) resulted in death, 31 (47.0%) required hospitalization.
Is Leukaemia recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PONATINIB. However, 66 reports have been filed with the FAERS database.
What Other Side Effects Does PONATINIB Cause?
Death (1,735)
Off label use (1,071)
Product dose omission issue (817)
Fatigue (687)
Rash (639)
Headache (553)
Pyrexia (542)
Nausea (466)
Hospitalisation (459)
Constipation (435)
What Other Drugs Cause Leukaemia recurrent?
METHOTREXATE (169)
CYTARABINE (146)
IMATINIB (138)
CYCLOPHOSPHAMIDE (134)
FLUDARABINE (107)
VINCRISTINE (103)
DEXAMETHASONE (91)
VENETOCLAX (81)
TRETINOIN (75)
DASATINIB (70)
Which PONATINIB Alternatives Have Lower Leukaemia recurrent Risk?
PONATINIB vs PONATINIB\PONATINIB
PONATINIB vs PONESIMOD
PONATINIB vs PORACTANT ALFA
PONATINIB vs PORFIMER
PONATINIB vs POSACONAZOLE